Menu
Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 8
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
Authors Anagnostou T, Litzow MR
Received 28 March 2018
Accepted for publication 31 March 2018
Published 11 April 2018 Volume 2018:8 Pages 11—12
Anagnostou T, Litzow MR. Blood Lymphat Cancer.
2018;8:1–9.
On page 2, Table 1 was incorrectly presented.
Read the original article
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.